Kingdom of DenmarkZealand announces management change

Zealand Pharma is set to make a series of restructuring changes that will shake-up a number of positions at the firm. Among these is current VP for investor relations and corporate communications Hanne Leth Hillman, who has been appointed to the new position as senior VP for investor relations and communications.

Hillman has been with the company since 2011. She was previously the vice president, director of investor relations and director of investor & capital market relations at NeuroSearch Sweden AB and NeuroSearch A/S. She also served as an analyst at Gudme Raaschou Bank A/S, Research Division; WestLB AG, Research Division and Jyske Bank A/S, Research Division. 

Zealand Pharma is a biotechnology company based in Copenhagen, Denmark. Zealand has leading expertise in the discovery, design and development of novel peptide medicines, in-house competences in clinical trial design and management and a therapeutic focus on cardio-metabolic diseases. The company has a broad portfolio of therapeutic products – both proprietary and partnered. 

2015
Senior VP Investor Relations and Communications